Literature DB >> 20703010

Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.

Soichiro Ide1, Shunsuke Fujiwara, Masayuki Fujiwara, Ichiro Sora, Kazutaka Ikeda, Masabumi Minami, George R Uhl, Kumatoshi Ishihara.   

Abstract

Although the opioid system is known to modulate depression-like behaviors, its role in the effects of antidepressants is not yet clear. We investigated the role of μ-opioid receptors (MOPs) in the effects of venlafaxine, a serotonin and norepinephrine reuptake inhibitor, in the forced swim test using MOP-knockout (KO) mice. Venlafaxine reduced immobility time in wild-type mice (C57BL/6J), but not in MOP-KO mice, although no significant effects were observed on locomotor activity. These results suggest that MOPs play an important role in the antidepressant-like effects of venlafaxine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703010      PMCID: PMC3171132          DOI: 10.1254/jphs.10136sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  15 in total

Review 1.  Molecular control of locus coeruleus neurotransmission.

Authors:  E J Nestler; M Alreja; G K Aghajanian
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

2.  Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.

Authors:  I Sora; G Elmer; M Funada; J Pieper; X F Li; F S Hall; G R Uhl
Journal:  Neuropsychopharmacology       Date:  2001-07       Impact factor: 7.853

3.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia.

Authors:  I Sora; N Takahashi; M Funada; H Ujike; R S Revay; D M Donovan; L L Miner; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice.

Authors:  Jakub Fichna; Anna Janecka; Mariola Piestrzeniewicz; Jean Costentin; Jean-Claude do Rego
Journal:  Neuropsychopharmacology       Date:  2006-07-05       Impact factor: 7.853

5.  Involvement of endogenous opioids with forced swimming-induced immobility in mice.

Authors:  S Amir
Journal:  Physiol Behav       Date:  1982-02

6.  In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.

Authors:  Esther Berrocoso; Juan Antonio Mico
Journal:  J Pharmacol Exp Ther       Date:  2007-04-12       Impact factor: 4.030

7.  Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.

Authors:  L A Dawson; H Q Nguyen; A Geiger
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

8.  Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice.

Authors:  Soichiro Ide; Ichiro Sora; Kazutaka Ikeda; Masabumi Minami; George R Uhl; Kumatoshi Ishihara
Journal:  Neuropharmacology       Date:  2009-07-14       Impact factor: 5.250

9.  Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.

Authors:  E A Muth; J T Haskins; J A Moyer; G E Husbands; S T Nielsen; E B Sigg
Journal:  Biochem Pharmacol       Date:  1986-12-15       Impact factor: 5.858

10.  Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone.

Authors:  V A Molina; C J Heyser; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

View more
  10 in total

1.  Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.

Authors:  Lauri Tuominen; Lauri Nummenmaa; Liisa Keltikangas-Järvinen; Olli Raitakari; Jarmo Hietala
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

2.  Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice.

Authors:  Jian-You Guo; Xiao-Ying Yuan; Feng Sui; Wen-Cai Zhang; Jin-Yan Wang; Fei Luo; Jing Luo
Journal:  Psychopharmacology (Berl)       Date:  2011-03-30       Impact factor: 4.530

3.  Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression.

Authors:  Sarah T Stahl; Changgi Jung; Debra K Weiner; Marta Peciña; Jordan F Karp
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

Review 4.  Placebo Analgesia in Rodents: Current and Future Research.

Authors:  Asaf Keller; Titilola Akintola; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-03-07       Impact factor: 3.230

Review 5.  Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.

Authors:  Claire Rampon; Bruno P Guiard; Basile Coutens; Antoine Yrondi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-10       Impact factor: 4.415

6.  In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor.

Authors:  Joseph J Casal-Dominguez; Mary Clark; John R Traynor; Stephen M Husbands; Sarah J Bailey
Journal:  J Psychopharmacol       Date:  2012-10-31       Impact factor: 4.153

Review 7.  Advances in novel molecular targets for antidepressants.

Authors:  Qingzhong Wang; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-16       Impact factor: 5.067

8.  Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats.

Authors:  Fu-Rong Wang; Ming-Qi Qiao; Ling Xue; Sheng Wei
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

9.  Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.

Authors:  Soichiro Ide; Takehiro Takahashi; Yukio Takamatsu; George R Uhl; Hiroaki Niki; Ichiro Sora; Kazutaka Ikeda
Journal:  Int J Neuropsychopharmacol       Date:  2017-05-01       Impact factor: 5.176

Review 10.  Applications of magnetic resonance imaging for treatment-resistant late-life depression.

Authors:  Christian Agudelo; Howard J Aizenstein; Jordan F Karp; Charles F Reynolds
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.